TCL Archive DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program July 3, 1981
TCL Archive UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer June 26, 2013
TCL Archive In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs November 27, 1998